SeaStar Medical Holding Corp (ICU): Nasdaq/NYSE listing notice — SeaStar Medical receives Nasdaq deficiency notice for MVLS below $35M minimum

SeaStar Medical Holding Corp

Nasdaq letter dated June 14, 2023: MVLS below $35M for 35 consecutive business days.
Company has 180 days (until Dec 11, 2023) to regain compliance by closing at $35M+ for 10 consecutive days.
No immediate delisting; stock continues trading on Nasdaq Capital Market.
Company considering options including extension request or appeal to Nasdaq Hearings Panel.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

SeaStar Medical Holding Corp received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: market value
Rules: 5550(b)(2)

Exact text from the filing

June 14, 2023, SeaStar Medical Holding Corporation (the “Company”) received a letter (the “Nasdaq Staff Deficiency Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, for the last thirty-five (35) consecutive business days, the Market Value of Listed Securities (“MVLS”) for the Company’s common stock, par value $0.0001 per share, had been below the $35 million minimum requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(2). In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company has been provided an initial period of 180

View on SEC.gov

Browse all listing & compliance notices →

SeaStar Medical Holding Corp filing history →

Source: SEC EDGAR

accession 0000929638-23-001741

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.